Geode Capital Management’s RayzeBio RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-434,891
Closed -$27M – 4686
2023
Q4
$27M Buy
434,891
+390,406
+878% +$9.7M ﹤0.01% 1728
2023
Q3
$988K Buy
+44,485
New +$934K ﹤0.01% 3324

Geode Capital Management's RYZB Position: Q1 2024 in Review

Geode Capital Management sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 434,891 shares — an estimated $27M sold.

Geode Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $27M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Geode Capital Management reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 434,891 RayzeBio shares in Q1 2024, an estimated $27M.
  • Geode Capital Management first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
  • Geode Capital Management's RayzeBio position peaked at $27M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.